Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood|November 15, 1990
Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granulesR A Fava, T T Casey, J Wilcox, et al.
Science (New York, N.Y.)|September 3, 1993
Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40F H Durie, R A Fava, T M Foy, et al.
Journal of Lipid Research|December 1, 1996
LY295427, a novel hypocholesterolemic agent, enhances [3H]25-hydroxycholesterol binding to liver cytosolic proteinsN Bowling, W F Matter, R A Gadski, et al.
Bio/Technology (Nature Publishing Company)|July 1, 1990
Characterization and novel purification of recombinant human protein C from three mammalian cell linesS C Yan, P Razzano, Y B Chao, et al.
Neuroscience|January 5, 2000
Suppression of an amyloid beta peptide-mediated calcium channel response by a secreted beta-amyloid precursor proteinW Y Li, J P Butler, J E Hale, et al.
Steroids|September 25, 1999
Synthesis and in vitro biological activity of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha,12 alpha-diol, a 12alpha-hydroxyl analog of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha-ol: the latter is a potent activator of the low-density lipoprotein receptor promoterH S Lin, A A Rampersaud, L S Beavers, et al.
The Journal of Experimental Medicine|May 1, 1991
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasiaR A Fava, N J Olsen, A E Postlethwaite, et al.
Nature|July 4, 1991
Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolutionJ P Wery, R W Schevitz, D K Clawson, et al.
The Journal of Biological Chemistry|March 25, 1990
Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domainP J Burck, D H Berg, M W Warrick, et al.
Steroids|July 10, 1999
Synthesis and in vitro biological activity of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha-ol: a 24,25-dehydro analog of the hypocholesterolemic agent 4alpha-(2-propenyl)-5alpha-cholestan-3alpha-olH S Lin, A A Rampersaud, M E Richett, et al.
Pageof 5